Oaktop Capital Management II L.P. Purchases New Position in Aspen Aerogels, Inc. $ASPN

Oaktop Capital Management II L.P. purchased a new position in Aspen Aerogels, Inc. (NYSE:ASPN) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 5,168,674 shares of the construction company’s stock, valued at approximately $32,769,000. Aspen Aerogels accounts for about 1.4% of Oaktop Capital Management II L.P.’s investment portfolio, making the stock its 6th biggest holding. Oaktop Capital Management II L.P. owned 6.24% of Aspen Aerogels at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of ASPN. Rice Hall James & Associates LLC raised its stake in shares of Aspen Aerogels by 9.2% during the 1st quarter. Rice Hall James & Associates LLC now owns 1,552,628 shares of the construction company’s stock worth $5,310,000 after buying an additional 131,023 shares during the period. Needham Investment Management LLC grew its stake in Aspen Aerogels by 26.5% in the 4th quarter. Needham Investment Management LLC now owns 4,351,700 shares of the construction company’s stock valued at $12,315,000 after acquiring an additional 912,000 shares during the period. Lazard Asset Management LLC acquired a new stake in Aspen Aerogels in the 1st quarter valued at $485,000. First Eagle Investment Management LLC increased its holdings in Aspen Aerogels by 20.3% in the 4th quarter. First Eagle Investment Management LLC now owns 622,487 shares of the construction company’s stock worth $1,762,000 after acquiring an additional 105,164 shares in the last quarter. Finally, Pallas Capital Advisors LLC purchased a new stake in Aspen Aerogels in the 2nd quarter worth $69,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Stock Performance

NYSE:ASPN opened at $5.83 on Tuesday. The company has a market cap of $483.83 million, a P/E ratio of -3.81 and a beta of 2.99. Aspen Aerogels, Inc. has a twelve month low of $2.30 and a twelve month high of $9.35. The company’s 50-day moving average price is $5.52 and its 200-day moving average price is $4.53. The company has a current ratio of 2.52, a quick ratio of 2.24 and a debt-to-equity ratio of 0.36.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Thursday, August 6th. The construction company reported ($0.22) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.01. The company had revenue of $49.85 million during the quarter, compared to analysts’ expectations of $42.42 million. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 31.12%. Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. On average, sell-side analysts forecast that Aspen Aerogels, Inc. will post -0.69 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Wall Street Zen downgraded shares of Aspen Aerogels from a “hold” rating to a “sell” rating in a report on Saturday. Roth Capital reissued a “buy” rating and set a $7.75 target price on shares of Aspen Aerogels in a research note on Friday, August 7th. B. Riley Financial reaffirmed a “buy” rating on shares of Aspen Aerogels in a research note on Friday, August 7th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a report on Wednesday, June 24th. Finally, Barclays boosted their price objective on Aspen Aerogels from $4.00 to $5.00 and gave the stock an “underweight” rating in a research note on Tuesday, August 11th. Four investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $5.94.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.